申请人:British Biotech Pharmaceuticals Ltd.
公开号:US06028110A1
公开(公告)日:2000-02-22
A pharmaceutical or veterinary composition comprising a compound of formula I ##STR1## wherein X is a --CO.sub.2 H group and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 are as defined in the specification, or a salt, hydrate or solvate thereof, and a pharmaceutically or veterinarily acceptable excipient or carrier. A method of treatment of diseases or conditions mediated by MMPs in mammals, such as rheumatoid arthritis, osteoarthritis, periodontitis, gingivitis, corneal ulceration or tumour invasion by secondary means, by administering to the mammal an effective amount of the composition.
一种包含式I的化学或兽药组合物##STR1##其中X是一个--CO.sub.2 H基团,R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5如规范中所定义,或其盐、水合物或溶剂化合物,以及一种药用或兽医学上可接受的赋形剂或载体。一种治疗哺乳动物中由MMPs介导的疾病或症状的方法,例如类风湿性关节炎、骨关节炎、牙周炎、牙龈炎、角膜溃疡或肿瘤侵袭等,通过向哺乳动物投与所述组合物的有效量。